These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 3014970

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Naloxazone irreversibly inhibits the high affinity binding of [125I]D-ala2-D-leu5-enkephalin.
    Hazum E, Chang KJ, Cuatrecasas P, Pasternak GW.
    Life Sci; 1981 Jun 29; 28(26):2973-9. PubMed ID: 6267402
    [No Abstract] [Full Text] [Related]

  • 7. Effects of calcium-channel blockers (CCB) on mu and delta opioid receptors in rat brain membranes.
    Schwarz S, Katki AG.
    Prog Clin Biol Res; 1990 Jun 29; 328():109-12. PubMed ID: 2154761
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tyr1-substituted and fluorescent Pya1-enkephalins bind strongly and selectively to mu and delta opiate receptors.
    Mihara H, Lee S, Shimohigashi Y, Aoyagi H, Kato T, Izumiya N, Costa T.
    Biochem Biophys Res Commun; 1986 May 14; 136(3):1170-6. PubMed ID: 3013169
    [Abstract] [Full Text] [Related]

  • 11. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
    Mosberg HI, Hurst R, Hruby VJ, Gee K, Yamamura HI, Galligan JJ, Burks TF.
    Proc Natl Acad Sci U S A; 1983 Oct 14; 80(19):5871-4. PubMed ID: 6310598
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD, Leslie JB, Su YF, Watkins WD, Chang KJ.
    J Pharmacol Exp Ther; 1987 Jan 14; 240(1):150-8. PubMed ID: 3027302
    [Abstract] [Full Text] [Related]

  • 16. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F, Heyman JS, Mosberg HI, Omnaas JR, Vaught JL.
    J Pharmacol Exp Ther; 1987 May 14; 241(2):393-400. PubMed ID: 3033214
    [Abstract] [Full Text] [Related]

  • 17. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y, Waki M, Izumiya N, Costa T, Herz A, Kurono M, Yagi K.
    Biochem Int; 1986 Aug 14; 13(2):199-203. PubMed ID: 3021160
    [Abstract] [Full Text] [Related]

  • 18. A highly selective ligand for brain delta opiate receptors, a cyclopropyl(E)Phe(4)-enkephalin analog, suppresses mu receptor-mediated thermal analgesia by morphine.
    Shimohigashi Y, Takano Y, Kamiya H, Costa T, Herz A, Stammer CH.
    FEBS Lett; 1988 Jun 20; 233(2):289-93. PubMed ID: 2838332
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.